Colchicin treatment of COVID-19 presenting with cutaneous rash and myopericarditis.
作者信息
Recalcati Sebastiano, Piconi Stefania, Franzetti Marco, Barbagallo Tania, Prestinari Francesca, Fantini Fabrizio
机构信息
Dermatology Unit, ASST Lecco, Alessandro Manzoni Hospital, Lecco, Italy.
Infectious Diseases Unit, ASST Lecco, Alessandro Manzoni Hospital, Lecco, Italy.
出版信息
Dermatol Ther. 2020 Nov;33(6):e13891. doi: 10.1111/dth.13891. Epub 2020 Jul 12.
Abstract
摘要
相似文献
1
Colchicin treatment of COVID-19 presenting with cutaneous rash and myopericarditis.秋水仙碱治疗出现皮疹和心肌心包炎的新型冠状病毒肺炎
Dermatol Ther. 2020 Nov;33(6):e13891. doi: 10.1111/dth.13891. Epub 2020 Jul 12.
2
Enanthem in Patients With COVID-19 and Skin Rash.COVID-19 患者的口咽部黏膜疹和皮疹。
JAMA Dermatol. 2020 Oct 1;156(10):1134-1136. doi: 10.1001/jamadermatol.2020.2550.
3
Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.局限于头颈部的孤立性斑丘疹：一种新型冠状病毒肺炎感染的皮肤体征。
Dermatol Ther. 2020 Nov;33(6):e14468. doi: 10.1111/dth.14468. Epub 2020 Nov 9.
4
Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation.新型冠状病毒感染中的皮肤感觉过敏：罕见但并非独特的临床表现。
Acta Derm Venereol. 2021 Jan 5;101(1):adv00366. doi: 10.2340/00015555-3729.
5
Follicular eruption as a cutaneous manifestation in COVID-19.滤泡性皮疹作为新型冠状病毒肺炎的一种皮肤表现
BMJ Case Rep. 2020 Oct 29;13(10):e238182. doi: 10.1136/bcr-2020-238182.
6
A case of COVID-19 with papulovesicular rash that progressed to retiform purpura, accompanied by cherry angiomas.一例伴有疱疹样皮疹进展为网状青斑的 COVID-19 病例，伴有樱桃状血管瘤。
Sao Paulo Med J. 2021 Mar-Apr;139(2):186-189. doi: 10.1590/1516-3180.2020.0620.R1.0212020.
7
Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.皮肤病变与新型冠状病毒肺炎：1例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）检测阳性病例的囊性疼痛性病变
Dermatol Ther. 2020 Nov;33(6):e14266. doi: 10.1111/dth.14266. Epub 2020 Sep 14.
8
Onychomadesis following COVID-19 infection: Is there a relationship?新型冠状病毒肺炎感染后的甲脱离：存在关联吗？
Dermatol Ther. 2020 Nov;33(6):e14309. doi: 10.1111/dth.14309. Epub 2020 Sep 25.
9
Human Herpesvirus-7 Papular Rash in a Healthy Adult Patient.一名健康成年患者身上的人疱疹病毒7型丘疹性皮疹
Acta Derm Venereol. 2017 Apr 6;97(4):537-538. doi: 10.2340/00015555-2567.
10
[Colchicine treatment for recurrent pericarditis].秋水仙碱治疗复发性心包炎
An Med Interna. 1997 Feb;14(2):98-100.
引用本文的文献
1
The Impact of COVID-19 on the Cardiovascular Health of Emerging Adults Aged 18-25: Findings From a Scoping Review.新冠疫情对18至25岁青年心血管健康的影响：一项范围综述的结果
CJC Pediatr Congenit Heart Dis. 2022 Dec 1;2(1):33-50. doi: 10.1016/j.cjcpc.2022.11.005. eCollection 2023 Feb.
2
A Systematic Review of COVID-19 and Pericarditis.新型冠状病毒肺炎与心包炎的系统评价
Cureus. 2022 Aug 12;14(8):e27948. doi: 10.7759/cureus.27948. eCollection 2022 Aug.
3
Dermatology and COVID-19: The Hidden Pandemic.皮肤病学与2019冠状病毒病：隐匿的大流行
J Clin Med. 2022 Jul 28;11(15):4397. doi: 10.3390/jcm11154397.
4
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.免疫失调和高凝状态作为新冠病毒感染的病理生理背景及秋水仙碱的免疫调节作用
J Clin Med. 2021 Oct 31;10(21):5128. doi: 10.3390/jcm10215128.
5
COVID-19: The Italian experience.COVID-19：意大利的经验。
Clin Dermatol. 2021 May-Jun;39(3):418-423. doi: 10.1016/j.clindermatol.2021.01.013. Epub 2021 Feb 1.
6
COVID-19: The experience from Italy.COVID-19：来自意大利的经验。
Clin Dermatol. 2021 Jan-Feb;39(1):12-22. doi: 10.1016/j.clindermatol.2020.12.008. Epub 2020 Dec 17.
7
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress.严重急性呼吸综合征冠状病毒2介导的内皮功能障碍：慢性氧化应激的潜在作用
Front Physiol. 2021 Jan 15;11:605908. doi: 10.3389/fphys.2020.605908. eCollection 2020.
本文引用的文献
1
Dermatological therapies with relevance to COVID-19.与 COVID-19 相关的皮肤科疗法。
Dermatol Ther. 2020 Nov;33(6):e13813. doi: 10.1111/dth.13813. Epub 2020 Jul 5.
2
Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak.多西环素，一种在皮肤科广泛使用的抗生素，在新冠疫情中可能对白细胞介素-6具有抗炎作用。
Dermatol Ther. 2020 Jul;33(4):e13437. doi: 10.1111/dth.13437. Epub 2020 May 15.
3
Treatment options for COVID-19: The reality and challenges.治疗 COVID-19 的选择：现实与挑战。
J Microbiol Immunol Infect. 2020 Jun;53(3):436-443. doi: 10.1016/j.jmii.2020.03.034. Epub 2020 Apr 4.
4
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design.希腊研究科维德-19 并发症预防中的秋水仙碱作用（GRECCO-19 研究）：原理和研究设计。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):42-45. doi: 10.1016/j.hjc.2020.03.002. Epub 2020 Apr 3.
5
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎（COVID-19）患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
6
Cutaneous manifestations in COVID-19: a first perspective.新型冠状病毒肺炎的皮肤表现：初步观点
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
7
Colchicine--Update on mechanisms of action and therapeutic uses.秋水仙碱——作用机制与治疗用途的最新进展
Semin Arthritis Rheum. 2015 Dec;45(3):341-50. doi: 10.1016/j.semarthrit.2015.06.013. Epub 2015 Jun 26.
8
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome.微管驱动的线粒体空间排列促进 NLRP3 炎性小体的激活。
Nat Immunol. 2013 May;14(5):454-60. doi: 10.1038/ni.2550. Epub 2013 Mar 17.
Zotero 插件